Aligos Therapeutics, Inc. (ALGS) vs Scilex Holding Company (SCLX)

A side-by-side comparison of Aligos Therapeutics, Inc. and Scilex Holding Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGS vs SCLX

growth of $100 · dividends reinvested · last 6y
ALGS -99.0% (-53.6%/yr)SCLX -98.9% (-52.8%/yr)SCLX compounded faster over this window
050100150Start $10020222023202420252026$1$1
ALGS SCLX

ALGS vs SCLX: by the numbers

  • •SCLX is the larger company ($34M vs $33M market cap).
  • •Both run net losses; ALGS's is the smaller (-241.01% vs -1414.57% net margin).
  • •SCLX grew revenue faster over the past five years (3.58% vs -15.85% CAGR).

Metrics side by side

Valuation

MetricALGSSCLX
P/S ratio1.061.06
P/B ratio1.04N/A

Profitability

MetricALGSSCLX
Gross margin57.46%49.68%
Operating margin-4024.93%-903.52%
Net margin-241.01%-1414.57%
ROE-238.24%N/A
ROIC-207.97%N/A

Growth (annualized)

MetricALGSSCLX
Revenue CAGR (5Y)-15.85%3.58%
Total return CAGR (5Y)-57.15%-59.50%

Frequently asked

Which has grown faster, ALGS or SCLX?
Over the past five years, SCLX grew revenue faster — ALGS at a -15.85% CAGR versus SCLX at 3.58%.
How have ALGS and SCLX total returns compared?
Over the past 5 years, ALGS delivered -57.15% and SCLX delivered -59.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.